SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEMAGEN DIAGNOSTICS (HMGN)
HMGN 0.0150+14,901.5%Aug 12 10:48 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Neurogenesis who wrote (15)12/21/1998 1:50:00 PM
From: Walter Morton  Read Replies (1) of 98
 
With the price at $.75 and the p/e ratio below eleven HMGN must be looking good to CIST now. HMGN is ripe for the taking. If HMGN drops anymore CIST will have to compete with a lot of other companies to buy or merge with HMGN.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News